Minerva Neurosciences, Inc. Foreign Currency Transaction Gain (Loss), Unrealized
Minerva Neurosciences, Inc. (NERV) reported Foreign Currency Transaction Gain (Loss), Unrealized of -$2.65 thousand for the 3-month period ending 2014-03-31, per its 10-Q filed 2015-05-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:ForeignCurrencyTransactionGainLossUnrealized · last filed 2015-05-07
- Minerva Neurosciences, Inc. foreign currency transaction gain (loss), unrealized for the quarter ending 2014-03-31 was -$2.65K.
- Minerva Neurosciences, Inc. foreign currency transaction gain (loss), unrealized for the quarter ending 2013-12-31 was -$24.66K.
- Minerva Neurosciences, Inc. foreign currency transaction gain (loss), unrealized for fiscal 2013 was -$22.04K.
| Period end | Foreign Currency Transaction Gain (Loss), Unrealized 3 month | Foreign Currency Transaction Gain (Loss), Unrealized 6 month | Foreign Currency Transaction Gain (Loss), Unrealized 9 month | Foreign Currency Transaction Gain (Loss), Unrealized 12 month |
|---|---|---|---|---|
| 2014-03-31 | -$2.65K 10-Q · filed 2015-05-07 | -$27.32K derived: sum of 2 quarters · filed 2015-05-07 | ||
| 2013-12-31 | -$24.66K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-26 | -$22.04K 10-K · filed 2015-03-26 | ||
| 2013-09-30 | $2.63K 10-Q · filed 2014-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |